Myofunctional Therapy in Facial Palsy

NACompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

December 31, 2005

Study Completion Date

December 31, 2006

Conditions
Facial Paralysis
Interventions
DRUG

Botulinum Toxin Type A

All the patients received a one-time treatment with botulinum toxin type A to the non-paralyzed side, according to the Institution Protocol,the total dose used per patient ranged from 15-69U, mean 37.9±5.4U.

PROCEDURE

myofunctional therapy

All the patients were submitted to individual myofunctional therapy with the speech therapist, once a week, by four weeks.The myofunctional therapy began with isometric maneuvers for muscular elongation on the non paralyzed side, and on the paralyzed side when microsurgical reconstruction was present. It also included isotonic maneuvers to increase muscle tonus and isokinetic maneuvers to increase force on the paralyzed side.

Trial Locations (1)

05403-000

University of Sao Paulo General Hospital, São Paulo

All Listed Sponsors
lead

University of Sao Paulo General Hospital

OTHER

NCT00989209 - Myofunctional Therapy in Facial Palsy | Biotech Hunter | Biotech Hunter